10x Genomics (TXG) EV to CFO (2019 - 2026)

10x Genomics has disclosed EV to CFO across 8 years of filings, most recently posting 261.75 for Q2 2026.

• In Q2 2026, EV to CFO rose 366.41% year-over-year to 261.75; the TTM figure through Jun 2026 stood at 34.96 (up 135.53% YoY), while the FY2025 annual figure was 11.46, down 94.4% from the prior year.
• EV to CFO came in at 261.75 for Q2 2026 at 10x Genomics, up from 84.17 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 274.56 in Q4 2022 to a low of 1469.82 in Q1 2023.
• Average EV to CFO over 5 years is 124.04, with a median of 20.97 recorded in 2025.
• Year-over-year, EV to CFO slumped 278.52% in 2023 and jumped 366.41% in 2026.
• Over 5 years, EV to CFO stood at 274.56 in 2022, then slipped by 11.26% to 243.65 in 2023, then sank by 182.88% to 201.94 in 2024, then surged by 118.94% to 38.24 in 2025, then soared by 584.53% to 261.75 in 2026.
• Per Business Quant data, the three most recent EV to CFO figures were 261.75 in Q2 2026, 84.17 in Q1 2026, and 38.24 in Q4 2025.